[1]
|
Gros, B. and Kaplan, G.G. (2023) Ulcerative Colitis in Adults: A Review. JAMA, 330, 951-965. https://doi.org/10.1001/jama.2023.15389
|
[2]
|
Low, E.N.D., Mokhtar, N.M., Wong, Z., et al. (2019) Colonic Mucosal Transcriptomic Changes in Patients with Long-Duration Ulcerative Colitis Revealed Colitis-Associated Cancer Pathways. Journal of Crohn’s and Colitis, 13, 755-763. https://doi.org/10.1093/ecco-jcc/jjz002
|
[3]
|
Xin, P., Xu, X., Deng, C., et al. (2020) The Role of JAK/STAT Signaling Pathway and Its Inhibitors in Diseases. International Immunopharmacology, 80, Article ID: 106210. https://doi.org/10.1016/j.intimp.2020.106210
|
[4]
|
Pedersen, J., Coskun, M., Soendergaard, C., et al. (2014) Inflammatory Pathways of Importance for Management of Inflammatory Bowel Disease. World Journal of Gastroenterology, 20, 64-77. https://doi.org/10.3748/wjg.v20.i1.64
|
[5]
|
Kim, J.T., Napier, D.L., Kim, J., et al. (2021) Ketogenesis Alleviates TNFα-Induced Apoptosis and Inflammatory Responses in Intestinal Cells. Free Radical Biology and Medicine, 172, 90-100. https://doi.org/10.1016/j.freeradbiomed.2021.05.032
|
[6]
|
Zhao, D., Qin, D., Yin, L., et al. (2023) Integrated Bioinformatics Analysis and Experimental Verification of Immune Cell Infiltration and the Related Core Genes in Ulcerative Colitis. Pharmacogenomics and Personalized Medicine, 16, 629-643. https://doi.org/10.2147/PGPM.S406644
|
[7]
|
Tontonoz, P. and Spiegelman, B.M. (2008) Fat and Beyond: The Diverse Biology of PPARγ. Annual Review of Biochemistry, 77, 289-312. https://doi.org/10.1146/annurev.biochem.77.061307.091829
|
[8]
|
Ricote, M., Huang, J., Fajas, L., et al. (1998) Expression of The Peroxisome Proliferator-Activated Receptor γ (PPARgamma) in Human Atherosclerosis and Regulation in Macrophages by Colony Stimulating Factors and Oxidized Low Density Lipoprotein. Proceedings of the National Academy of Sciences of the United States of America, 95, 7614-7619. https://doi.org/10.1073/pnas.95.13.7614
|
[9]
|
Lefebvre, M., Paulweber, B., Fajas, L., et al. (1999) Peroxisome Proliferator-Activated Receptor γ Is Induced During Differentiation of Colon Epithelium Cells. Journal of Endocrinology, 162, 331-340. https://doi.org/10.1677/joe.0.1620331
|
[10]
|
Clark, R.B., Bishop-Bailey, D., Estrada-Hernandez, T., et al. (2000) The Nuclear Receptor PPAR γ and Immunoregulation: PPAR γ Mediates Inhibition of Helper T Cell Responses. The Journal of Immunology, 164, 1364-1371. https://doi.org/10.4049/jimmunol.164.3.1364
|
[11]
|
Cordes, F., Foell, D., Ding, J.N., et al. (2020) Differential Regulation of JAK/STAT-Signaling in Patients with Ulcerative Colitis and Crohn’s Disease. World Journal of Gastroenterology, 26, 4055-4075. https://doi.org/10.3748/wjg.v26.i28.4055
|
[12]
|
Caiazzo, G., Caiazzo, A., Napolitano, M., et al. (2023) The Use of JAK/STAT Inhibitors in Chronic Inflammatory Disorders. Journal of Clinical Medicine, 12, Article 2865. https://doi.org/10.3390/jcm12082865
|
[13]
|
吴开春, 梁洁, 冉志华, 等. 炎症性肠病诊断与治疗的共识意见(2018年∙北京) [J]. 中国实用内科杂志, 2018, 38(9): 796813.
|
[14]
|
Le Berre, C., Honap, S. and Peyrin-Biroulet, L. (2023) Ulcerative Colitis. Lancet, 402, 571-584. https://doi.org/10.1016/S0140-6736(23)00966-2
|
[15]
|
Ungaro, R., Colombel, J.F., Lissoos, T., et al. (2019) A Treat-to-Target Update in Ulcerative Colitis: A Systematic Review. The American Journal of Gastroenterology, 114, 874-883. https://doi.org/10.14309/ajg.0000000000000183
|
[16]
|
Ordás, I., Eckmann, L., Talamini, M., et al. (2012) Ulcerative Colitis. Lancet, 380, 1606-1619. https://doi.org/10.1016/S0140-6736(12)60150-0
|
[17]
|
Leikin, J.B. (2019) A Comprehensive Review and Update on Ulcerative Colitis Foreword. Disease-a-Month, 65, Article ID: 100852. https://doi.org/10.1016/j.disamonth.2019.02.005
|
[18]
|
Kim, J.T., Li, C., Weiss, H.L., et al. (2019) Regulation of Ketogenic Enzyme HMGCS2 by Wnt/β-Catenin/PPARγ Pathway in Intestinal Cells. Cells, 8, Article 1106. https://doi.org/10.3390/cells8091106
|
[19]
|
Fournier, B.M. and Parkos, C.A. (2012) The Role of Neutrophils during Intestinal Inflammation. Mucosal Immunology, 5, 354-366. https://doi.org/10.1038/mi.2012.24
|
[20]
|
Souza, R.F., Caetano, M.A, F., Magalhães, H.I, R., et al. (2023) Study of Tumor Necrosis Factor Receptor in the Inflammatory Bowel Disease. World Journal of Gastroenterology, 29, 2733-2746. https://doi.org/10.3748/wjg.v29.i18.2733
|
[21]
|
Martín-Adrados, B., Wculek, S.K., Fernández-Bravo, S., et al. (2023) Expression of HMGCS2 in Intestinal Epithelial Cells Is Downregulated in Inflammatory Bowel Disease Associated with Endoplasmic Reticulum Stress. Frontiers in Immunology, 14, Article 1185517. https://doi.org/10.3389/fimmu.2023.1185517
|
[22]
|
Kaur, A. and Goggolidou, P. (2020) Ulcerative Colitis: Understanding Its Cellular Pathology Could Provide Insights Into Novel Therapies. Journal of Inflammation, 17, Article No. 15. https://doi.org/10.1186/s12950-020-00246-4
|
[23]
|
Haberman, Y., Karns, R., Dexheimer, P.J., et al. (2019) Ulcerative Colitis Mucosal Transcriptomes Reveal Mitochondriopathy and Personalized Mechanisms Underlying Disease Severity and Treatment Response. Nature Communications, 10, Article No. 38. https://doi.org/10.1038/s41467-018-07841-3
|
[24]
|
Welch, J.S., Ricote, M., Akiyama, T.E., et al. (2003) PPARγ and PPARδ Negatively Regulate Specific Subsets of Lipopolysaccharide and IFN-γ Target Genes in Macrophages. Proceedings of the National Academy of Sciences of the United States of America, 100, 6712-6717. https://doi.org/10.1073/pnas.1031789100
|
[25]
|
Jiang, C., Ting, A.T. and Seed, B. (1998) PPAR-γ Agonists Inhibit Production of Monocyte Inflammatory Cytokines. Nature, 391, 82-86. https://doi.org/10.1038/34184
|
[26]
|
Vetuschi, A., Pompili, S., Gaudio, E., et al. (2018) PPAR-γ with Its Anti-Inflammatory and Anti-Fibrotic Action Could Be an Effective Therapeutic Target in IBD. European Review for Medical and Pharmacological Sciences, 22, 8839-8848.
|
[27]
|
Decara, J., Rivera, P., López-Gambero, A.J., et al. (2020) Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases. Frontiers in Pharmacology, 11, Article 730. https://doi.org/10.3389/fphar.2020.00730
|
[28]
|
Mudter, J., Weigmann, B., Bartsch, B., et al. (2005) Activation Pattern of Signal Transducers and Activators of Transcription (STAT) Factors in Inflammatory Bowel Diseases. American Journal of Gastroenterology, 100, 64-72. https://doi.org/10.1111/j.1572-0241.2005.40615.x
|
[29]
|
Bandyopadhyay, S.K., De La Motte, C.A., Kessler, S.P., et al. (2008) Hyaluronan-Mediated Leukocyte Adhesion and Dextran Sulfate Sodium-Induced Colitis Are Attenuated in the Absence of Signal Transducer and Activator of Transcription 1. The American Journal of Pathology, 173, 1361-1368. https://doi.org/10.2353/ajpath.2008.080444
|
[30]
|
Wu, F., Dassopoulos, T., Cope, L., et al. (2007) Genome-Wide Gene Expression Differences in Crohn’s Disease and Ulcerative Colitis from Endoscopic Pinch Biopsies: Insights into Distinctive Pathogenesis. Inflammatory Bowel Diseases, 13, 807-821. https://doi.org/10.1002/ibd.20110
|
[31]
|
Suzuki, A., Hanada, T., Mitsuyama, K., et al. (2001) CIS3/SOCS3/SSI3 Plays a Negative Regulatory Role in STAT3 Activation and Intestinal Inflammation. Journal of Experimental Medicine, 193, 471-481. https://doi.org/10.1084/jem.193.4.471
|